Pulmotherapeutics Inc. is a biopharmaceutical company dedicated to creating innovative therapies for respiratory diseases. It focuses on developing advanced treatments for severe pulmonary conditions, making use of cutting-edge technology.
Company Values
Utilizes AI and bio-simulation for accelerated drug development.